COST-EFFECTIVENESS OF GRAZOPREVIR / ELBASVIR IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS

被引：0
|
作者：
Mattingly, T. J., III [1 ]
Slejko, J. F. [1 ]
Mullins, C. D. [1 ]
机构：
[1] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.396
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN47
引用
收藏
页码：A415 / A415
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Elbasvir/Grazoprevir for the Treatment of Chronic Hepatitis C: A Systematic Review
    Liu, Jinyu
    Guo, Min
    Ke, Lei
    You, Ruxu
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [2] Cost-Effectiveness of Elbasvir/Grazoprevir Versus Daclatasvir Plus Asunaprevir in Patients with Chronic Hepatitis C Virus Genotype 1b Infection in China
    Chen, Pingyu
    Ma, Aixia
    Liu, Qiang
    CLINICAL DRUG INVESTIGATION, 2018, 38 (11) : 1031 - 1039
  • [3] Cost-Effectiveness of Elbasvir/Grazoprevir Versus Daclatasvir Plus Asunaprevir in Patients with Chronic Hepatitis C Virus Genotype 1b Infection in China
    Pingyu Chen
    Aixia Ma
    Qiang Liu
    Clinical Drug Investigation, 2018, 38 : 1031 - 1039
  • [4] Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection
    Chandana Papudesu
    Shyamasundaran Kottilil
    Shashwatee Bagchi
    Hepatology International, 2017, 11 : 152 - 160
  • [5] Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection
    Papudesu, Chandana
    Kottilil, Shyamasundaran
    Bagchi, Shashwatee
    HEPATOLOGY INTERNATIONAL, 2017, 11 (02) : 152 - 160
  • [6] Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China
    Liu, Jinyu
    Zhang, Yu
    Wu, Bin
    Wang, Sen
    Bin-Chia Wu, David
    You, Ruxu
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [7] EFFECTIVENESS OF ELBASVIR/GRAZOPREVIR ± SOFOSBUVIR IN POST SOLID ORGAN TRANSPLANT PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
    Ajlan, Aziza
    Ahmed, Mohamed
    Abu-Riash, Tamadhor
    Alkortas, Delal
    Alabdulkarim, Zinah
    Aljedai, Ahmed H.
    HEPATOLOGY, 2019, 70 : 980A - 980A
  • [8] Erratum to: Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection
    Chandana Papudesu
    Shyamasundaran Kottilil
    Shashwatee Bagchi
    Hepatology International, 2017, 11 : 315 - 316
  • [9] EFFECTIVENESS OF ELBASVIR/GRAZOPREVIR IN PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION RECEIVING DIALYSIS
    Puenpatom, Amy
    Kramer, Jennifer R.
    Cao, Yumei
    El-Serag, Hashem B.
    Kanwal, Fasiha
    GASTROENTEROLOGY, 2019, 156 (06) : S1346 - S1346
  • [10] Effectiveness of elbasvir/grazoprevir in patients with hepatitis C virus genotype 1 infection receiving dialysis
    Kramer, Jennifer
    Puenpatom, Amy
    Cao, Yumei
    El-Serag, Hashem
    Kanwal, Fasiha
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E237 - E237
12345